Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age
- 28 February 1997
- Vol. 15 (3) , 325-328
- https://doi.org/10.1016/s0264-410x(96)00161-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Laboratory Correlates of Protection against Haemophilus influenzae Type b DiseaseAnnals of the New York Academy of Sciences, 1995
- Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infantsJAMA, 1994
- Immunogenicity of Haemophilus influenzae Type b Tetanus Toxoid Conjugate Vaccine in Young InfantsThe Journal of Infectious Diseases, 1994
- Haemophilus influenzae type b polysaccharidetetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of ageThe Pediatric Infectious Disease Journal, 1993
- Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infantsThe Pediatric Infectious Disease Journal, 1993
- Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccinesVaccine, 1993
- Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infantsThe Journal of Pediatrics, 1992
- Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccineJAMA, 1992
- The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of ageThe Pediatric Infectious Disease Journal, 1991
- Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infantsThe Pediatric Infectious Disease Journal, 1991